Key Takeaways
- Record quarter, guidance raised: Revenue hit an all-time high of ₹360.7 crores, and management is now "pretty confident to do better than" the 80% YoY growth guidance, with a possible upgrade assessed by end of next quarter.
- Order book swells by ₹800 cr on results day: The closing order book of ₹5,143 crores was supplemented by incremental orders received on 30 July 2026, pushing the total well past the ₹5,000 cr year-end target already.
- Working capital transformation: Days plunged from 172 to 59, driven by better commercial terms and weekly monitoring, and the year-end target has been revised down to ~100 days.
- Nuclear moves from cyclical to structural: With the Kaiga 5 & 6 orders and PFBR criticality achieved, management declared the civil nuclear vertical has transitioned to a "consistent and sustainable growth trajectory with substantially reduced cyclicality."
- What to watch next quarter: Whether the ₹800 cr incremental order execution timeline firms up, the pace of the fuel cell Phase 2 ramp-up by October, and any formal guidance upgrade.
Revenue & Margin Performance
- Topline driven by product ramp-up: The record ₹360.7 crores revenue was driven by strong execution across products, with new product revenue now almost 50% of the Clean Energy segment run rate, fueled by aerospace, defense, and clean energy products developed over the past couple of years.
- Gross margin mix effect: Gross margin declined to 45.61% from 47.65% YoY due to a change in revenue mix, even as EBITDA margin improved sequentially to 23.54% from 20.11% on operating leverage and cost monitoring.
- PAT explodes on operating leverage: PAT grew 364.5% YoY, driven by multifold revenue growth from the strong order book and the production ramp-up of previously completed first-article products.
- Product division trajectory: The product division is the result of 1.5–2 years of work establishing first articles, infrastructure, and quality approvals, and has now moved into volume production for the majority of those first articles; management expects it might cross ₹1,000 crores in 3–4 years.
Srinivas Reddy: "We strongly believe that the company is at an inflection point, with each of our key business verticals positioned for next phase of growth."
Order Book & Demand Visibility
- Order book is short-cycle by design: The order book is not a 5–10 year backlog; it spans cycles from 2 months to 2 years, which management argues means a continuous order book is the norm rather than a lumpy, distant backlog.
- Aerospace & Defense doubling: The segment is expected to double revenues this fiscal year, driven largely by existing programs and qualified products now entering volume production, with further upside from new inquiries under discussion.
- Domestic defense pipeline: Volume orders are anticipated for actuator assemblies for LCA Tejas Mark-1A, wing kits, and electromechanical actuators for various defense programs.
- Data center entry: MTAR has entered the data center infrastructure solutions segment with an initial set of products in progress; upon successful qualification, a meaningful ramp-up is expected over the next year, with potential to scale to 8x the current order.
- Hydropower and wind traction: The company is witnessing good traction and continues to pursue select products in these areas.
Srinivas Reddy: "So, the best part of our order book, it's not like an order book which has to be executed over 5 years or 10 years, it's all short cycle. Some are within 1 year, some are within 6 months, some are within 2 months, some are within 1 and a half 2 years. So, it is something that continuous order book is going to happen."
Civil Nuclear: The Inflection Point
- Kaiga 5 & 6 driving near-term execution: Highest-ever order inflows were received during the quarter for these two reactors, with execution timelines ranging from 1 year to 3–3.5 years and a meaningful ramp-up expected in the second half of this fiscal year.
- Refurbishment orders stacking up: Refurbishment orders are to be executed within 2 years, with another ₹130–140 crores of inflows expected in the current quarter.
- Mahi Banswara opportunity is larger: The four-reactor tender already floated represents an opportunity much larger than Kaiga 5 & 6 for MTAR, with orders likely to come in the next financial year and participation routed through EPC vendors.
- PFBR opens a new front: With the Prototype Fast Breeder Reactor achieving criticality, the government is looking at setting up another couple of PFBR reactors, and details have already been sent to MTAR, which supplied the majority of critical assemblies for the first one.
- 100 GW by 2047: The government's target provides the long-term demand anchor, and management sees 4–6 reactors coming in as part of a massive ramp-up of the nuclear energy program over the next 2–3 years.
Srinivas Reddy: "We believe civil nuclear vertical has transitioned to a more consistent and sustainable growth trajectory with substantially reduced cyclicality compared to the past."
Clean Energy & Fuel Cells
- Record order inflows: The Clean Energy segment received record order inflows during the quarter, further strengthening the order book, and is expected to remain a major revenue driver by the end of this fiscal year.
- Fuel cell capacity build-out on track: Phase 1 is commissioned; Phase 2 is expected operational by September–October 2026; Phase 3, a multifold expansion, is to be commissioned by March 2027 with ramp-up from April onwards.
- Manpower readiness: The company has initiated manpower training and automation initiatives ahead of capacity coming on stream for fuel cells.
- Short-cycle execution: Clean fuel cell orders are to be executed over this year and next year, all short-cycle and to be executed as soon as possible, though management did not provide a specific execution cycle duration for the clean fuel cell backlog when asked.
Working Capital & Balance Sheet
- Days collapse to 59: Working capital days reduced from 172 in FY26 to 59, achieved through better commercial terms negotiated with customers, faster delivery enabling earlier receipt of money, daily/weekly monitoring of each element, and GST refund initiatives.
- Receivables halved: Receivables came down from 140 to 80 days, and receivables-plus-inventory days declined from ~340 to ~220, driven by the same actions.
- Year-end target revised down: The working capital target has been revised to ~100 days from the earlier 150–175 days, with a commitment to sustain below 100 days for the year.
- Net debt nearly zero: Net debt is effectively ~₹20–30 crores after adjusting investments of ₹379 crores, and interest cost is expected to decline quarter-on-quarter going forward.
- Cash flow surge: Cash flow from operations reached ₹247.69 crores, driven by the working capital initiatives and better commercial terms.
Gunneswara Rao: "We don't want to affect the margins in the company. As long as it is margins are better and everything is good, then only we can take any of the actions, but whatever we have done is organically we are able to reduce now."
Capex, Expansion & Return Metrics
- ₹500 cr capex over two years: Approximately ₹500 crores is required over FY27 and FY28 for existing expansion plans, with some spillover into the next 1–2 quarters of the following financial year.
- Asset turnover ambition: Management is targeting a minimum of 4–5 times asset turnover on capex spent, with an aspiration of 6x.
- ROCE target: ROCE is expected to reach 23% next year.
- Phase 1 complete: The Phase 1 expansion plan has been completed in all aspects.
- New facilities coming online: A dedicated aerospace facility and NADCAP-approved special processes facility have been established; a dedicated facility for data center infrastructure solutions is being set up; and the Oil & Gas facility will be operational by October 2026.
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Revenue growth | 80% YoY; management "pretty confident to do better" and may upgrade | FY27; upgrade assessed by end of next quarter |
| EBITDA margin | 24% ±100 bps | FY27 |
| Closing order book | Robust ₹5,000 crores (already exceeded with ₹5,143 cr + ₹800 cr incremental orders received today) | FY27 year-end |
| Working capital days | Sustain below 100 days | FY27 year-end |
| Receivables + inventory days | Sustain around 200–220 days | FY27 |
| Fuel cell Phase 2 | To be commissioned | September–October 2026 |
| Fuel cell Phase 3 | Multifold capacity expansion to be commissioned; ramp-up from April | March 2027 |
| Oil & Gas facility | Will be operational | October 2026 |
| Aerospace & Defense revenue | Double revenues | FY27 |
| ROCE | Reach 23% | Next year (FY28) |
| Capex | ~₹500 crores | FY27 and FY28 |
| Refurbishment order inflows | Another ₹130–140 crores expected | Current quarter (Q2 FY27) |
| Nuclear L1 order (~₹130 cr) | Expected to be received | Current quarter (Q2 FY27) |
Key Metrics
| Metric | Q1 FY27 |
|---|---|
| Revenue | ₹360.7 cr, +130.4% YoY |
| EBITDA | ₹85.1 cr, +199.7% YoY |
| EBITDA margin | 23.6%, in line with annual guidance of 24% ±100 bps; 20.11% in Q4 FY26 |
| Profit before tax | ₹67.4 cr, +355% YoY |
| Profit after tax | ₹50.2 cr, +364.5% YoY |
| PAT margin | 13.92%, vs 6.9% in Q1 FY26 |
| Gross margin | 45.61%, vs 47.65% in Q1 FY26; decline due to revenue mix |
| ROCE | 17.2%, vs 11.4% prior year; expected to reach 23% next year |
| Cash flow from operations | ₹247.69 cr, vs ₹191.66 cr in Q1 FY26 |
| Working capital days | 59 days, vs 172 days in full FY26; year-end target revised to ~100 days from 150–175 days |
| Net debt | ~₹20–30 cr, after adjusting ₹379 cr investments against ₹423.6 cr gross debt |
| Closing order book | ₹5,143 cr at quarter-end; additional ₹800 cr orders received on 30 July 2026 |
| Nuclear order book | ₹684 cr as of Q1; expecting additional ₹130–140 cr this quarter, total ~₹815 cr |
| Capex incurred in Q1 | ~₹35 cr spent; ₹80 cr capitalized from earlier capital WIP |
| FY27 revenue growth guidance | 80% YoY; management confident of doing better |
| FY27 EBITDA margin guidance | 24% ±100 bps; management confident of doing better |